{"id":"NCT02525796","sponsor":"Brigham and Women's Hospital","briefTitle":"Evaluating Alternative Medical Therapies in Primary Hyperparathyroidism","officialTitle":"Evaluating Alternative Medical Therapies in Primary Hyperparathyroidism","status":"COMPLETED","phase":"PHASE2","dates":{"start":"2016-01","primaryCompletion":"2021-10-01","completion":"2021-10-02","firstPosted":"2015-08-17","resultsPosted":"2023-05-03","lastUpdate":"2023-05-03"},"enrollment":69,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Primary Hyperparathyroidism"],"interventions":[{"type":"DRUG","name":"eplerenone","otherNames":[]},{"type":"DRUG","name":"amiloride","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]},{"type":"DRUG","name":"Cinacalcet","otherNames":[]}],"arms":[{"label":"Placebo + Cinacalcet","type":"PLACEBO_COMPARATOR"},{"label":"Amiloride + Cinacalcet","type":"ACTIVE_COMPARATOR"},{"label":"Eplerenone + Cinacalcet","type":"EXPERIMENTAL"}],"summary":"This study will evaluate whether blocking the mineralocorticoid receptor, alone, or in combination with the calcimimetic cinacalcet, can lower parathyroid hormone and calcium levels in primary hyperparathyroidism.","primaryOutcome":{"measure":"Change in Parathyroid Hormone Levels","timeFrame":"Change in circulating PTH levels before and after 4 weeks of double-blinded monotherapy intervention when compared to placebo (PTH at 4 weeks minus PTH at baseline)","effectByArm":[{"arm":"Eplerenone","deltaMin":4,"sd":null},{"arm":"Amiloride","deltaMin":-3.7,"sd":null},{"arm":"Placebo","deltaMin":0.8,"sd":null}],"pValues":[{"comp":"OG000 vs OG002","p":"0.84"},{"comp":"OG001 vs OG002","p":"0.54"},{"comp":"OG000 vs OG001","p":"0.58"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":2,"exclusionCount":13},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":14},"commonTop":["hyperkalemia","low egfr","hypocalcemia","low blood pressure"]}}